Sciclone Pharmaceuticals, Inc. (SCLN) Posts Mixed Q2 Results
Tweet Send to a FriendGet Alerts SCLN Hot Sheet
Price: $4.83 -2.82%
Financial Fact:
Income before provision for income tax: 3.79M
Today's EPS Names:
LBIX, ESEA, ISS, More
Financial Fact:
Income before provision for income tax: 3.79M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade SCLN Now!
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q2 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $40.3 million versus the consensus estimate of $41.98 million.
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Sciclone Pharmaceuticals, Inc. (SCLN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- Cisco Systems (CSCO) Tops Q3 EPS by 2c; Gross Margin Widens
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
